Within this 6-part podcast series, experts in the field evaluate the latest safety and efficacy findings pertaining to emerging therapies that may advance the treatment of neovascular diseases, as well as provide discussion on how these emerging therapies may be incorporated into real-world practice.
Available Episodes: Drug Delivery Systems in Neovascular Retinal Disease » Length: 15:29 Carl D. Regillo, MD, FACS (Host); Charles C. Wykoff, MD, PhD LISTEN NOW ▶ Inhibition of Ang-2: Potential Effect in AMD Treatment Paradigms » Length: 13:47 Carl D. Regillo, MD, FACS (Host); Jeffrey S. Heier, MD LISTEN NOW ▶ Inhibition of Ang-2: Potential Effect in DME Treatment Paradigms » Length: 14:36 Carl D. Regillo, MD, FACS (Host); Jeffrey S. Heier, MD LISTEN NOW ▶ Effective Treatment Interval Extensions in Neovascular Retinal Disease » Length: 14:22 Carl D. Regillo, MD, FACS (Host); Charles C. Wykoff, MD, PhD LISTEN NOW ▶ Sustained Suppression of VEGF – What is the Effect? Where is the Evidence? » Length: 16:35 Carl D. Regillo, MD, FACS (Host); Dante J. Pieramici, MD LISTEN NOW ▶ Effect of Subretinal Fluid on Visual Outcomes in Neovascular AMD » Length:14:25 Carl D. Regillo, MD, FACS (Host); Dante J. Pieramici, MD LISTEN NOW ▶ |
For more information visit: MedED Talks Website